Amyloid-beta oligomers are inefficiently measured by enzyme-linked immunosorbent assay - PubMed (original) (raw)
Amyloid-beta oligomers are inefficiently measured by enzyme-linked immunosorbent assay
Charlotte Stenh et al. Ann Neurol. 2005 Jul.
Abstract
Amyloid-beta (Abeta) peptide levels are widely measured by enzyme-linked immunosorbent assay (ELISA) in Alzheimer's disease research. Here, we show that oligomerization of Abeta results in underestimated Abeta ELISA levels. The implications are that comprehensive analysis of soluble Abeta requires either sample pretreatment at denaturing conditions or novel conformation-dependent immunoassays. Our findings might be of relevance for many neurodegenerative disorders in which soluble protein aggregates are the main neurotoxic species.
Similar articles
- Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL, Vassar R, Disterhoft JF. Ohno M, et al. Eur J Neurosci. 2006 Jan;23(1):251-60. doi: 10.1111/j.1460-9568.2005.04551.x. Eur J Neurosci. 2006. PMID: 16420434 - Sensitive ELISA detection of amyloid-beta protofibrils in biological samples.
Englund H, Sehlin D, Johansson AS, Nilsson LN, Gellerfors P, Paulie S, Lannfelt L, Pettersson FE. Englund H, et al. J Neurochem. 2007 Oct;103(1):334-45. doi: 10.1111/j.1471-4159.2007.04759.x. Epub 2007 Jul 10. J Neurochem. 2007. PMID: 17623042 - Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
Pihlaja R, Koistinaho J, Malm T, Sikkilä H, Vainio S, Koistinaho M. Pihlaja R, et al. Glia. 2008 Jan 15;56(2):154-63. doi: 10.1002/glia.20599. Glia. 2008. PMID: 18004725 - Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review.
Avila-Vazquez MF, Altamirano-Bustamante NF, Altamirano-Bustamante MM. Avila-Vazquez MF, et al. Molecules. 2017 Dec 29;23(1):79. doi: 10.3390/molecules23010079. Molecules. 2017. PMID: 29286329 Free PMC article. Review.
Cited by
- Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers.
Bisi N, Pinzi L, Rastelli G, Tonali N. Bisi N, et al. Molecules. 2024 Feb 4;29(3):722. doi: 10.3390/molecules29030722. Molecules. 2024. PMID: 38338465 Free PMC article. Review. - Bioinformatics tools and data resources for assay development of fluid protein biomarkers.
Waury K, Willemse EAJ, Vanmechelen E, Zetterberg H, Teunissen CE, Abeln S. Waury K, et al. Biomark Res. 2022 Nov 15;10(1):83. doi: 10.1186/s40364-022-00425-w. Biomark Res. 2022. PMID: 36380380 Free PMC article. Review. - Quantitative assessment of AD markers using naked eyes: point-of-care testing with paper-based lateral flow immunoassay.
Zhang L, Du X, Su Y, Niu S, Li Y, Liang X, Luo H. Zhang L, et al. J Nanobiotechnology. 2021 Nov 17;19(1):366. doi: 10.1186/s12951-021-01111-z. J Nanobiotechnology. 2021. PMID: 34789291 Free PMC article. - ELISA- and Activity Assay-Based Quantification of BMP-2 Released In Vitro Can Be Biased by Solubility in "Physiological" Buffers and an Interfering Effect of Chitosan.
Sundermann J, Sydow S, Burmeister L, Hoffmann A, Menzel H, Bunjes H. Sundermann J, et al. Pharmaceutics. 2021 Apr 19;13(4):582. doi: 10.3390/pharmaceutics13040582. Pharmaceutics. 2021. PMID: 33921903 Free PMC article. - Association of plasma β-amyloid 40 and 42 concentration with type 2 diabetes among Chinese adults.
Peng X, Xu Z, Mo X, Guo Q, Yin J, Xu M, Peng Z, Sun T, Zhou L, Peng X, Xu S, Yang W, Bao W, Shan Z, Li X, Liu L. Peng X, et al. Diabetologia. 2020 May;63(5):954-963. doi: 10.1007/s00125-020-05102-x. Epub 2020 Feb 7. Diabetologia. 2020. PMID: 32034441
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources